Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

MERCK KGAA : JP Morgan keeps its Buy rating

05/04/2021 | 08:05am EDT

Richard Vosser from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 160.


© MarketScreener with dpa-AFX Analyser 2021
All news about MERCK KGAA
05/07MERCK KGAA  : quaterly earnings release
05/07MERCK  : ALJ Bullock Grants-in-Part Motion For Summary Determination Of Violatio..
AQ
05/06MERCK KGAA  : Buy rating from Deutsche Bank
MD
05/05GLOBAL MARKETS LIVE : Lyft, Activision, General Electric...
05/05MERCK KGAA  : DZ Bank maintains a Buy rating
MD
05/05MERCK KGAA  : Warburg Research reaffirms its Neutral rating
MD
05/05MERCK KGAA  : UBS gives a Neutral rating
MD
05/05MERCK KGAA  : Sell rating from Goldman Sachs
MD
05/05MERCK KGAA  : JP Morgan keeps its Buy rating
MD
05/04Merck KGaA Raises 2021 Views After 'Very Strong' 1Q
DJ
More news
Financials
Sales 2021 18 596 M 22 578 M 22 578 M
Net income 2021 2 349 M 2 852 M 2 852 M
Net Debt 2021 9 319 M 11 314 M 11 314 M
P/E ratio 2021 25,8x
Yield 2021 1,04%
Capitalization 61 586 M 74 895 M 74 774 M
EV / Sales 2021 3,81x
EV / Sales 2022 3,50x
Nbr of Employees 58 127
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 146,51 €
Last Close Price 141,65 €
Spread / Highest target 23,5%
Spread / Average Target 3,43%
Spread / Lowest Target -22,3%
EPS Revisions
Managers and Directors
NameTitle
Belén Garijo López Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Nilesh Kumar Senior Investment Director
Christian Raabe Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA0.93%74 895
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD23.59%31 005
KYOWA KIRIN CO., LTD.19.05%16 579
SK BIOPHARMACEUTICALS CO., LTD.-36.09%7 602
BETTA PHARMACEUTICALS CO., LTD.-7.96%6 347
YUHAN CORPORATION-15.98%3 697